** Shares of medical device maker Angiodynamics ANGO.O rise 5.5% to $11.75 in premarket trading
** Co projects annual sales in the range of $308 million to $313 million, compared to a previous range of $305 million to $310 million; analysts on average expect full-year sales of $307.2 million as per LSEG data
** Co reports Q1 sales of $75.7 million, surpassing analysts' average estimate of $72.7 million
** As of last close, ANGO stock was up 20.8% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))